Logo image
High-sensitivity cardiac troponins: no more 'negatives'
Journal article   Peer reviewed

High-sensitivity cardiac troponins: no more 'negatives'

J H Gamble, E W Carlton, W P Orr and Kim Greaves
Expert review of cardiovascular therapy, Vol.11(9), pp.1129-1139
2013
url
https://doi.org/10.1586/14779072.2013.828978View
Published Version

Abstract

acute myocardial infarction cardiac diagnostic techniques cardiovascular chest pain high-sensitivity cardiac troponins troponin assays troponin
According to recently published expert guidelines, cardiac troponins are the only accepted biomarkers to define acute myocardial infarction. New high sensitivity cardiac troponin assays provide exciting opportunities for early rule-out and rule-in strategies and for identifying high-risk patients early in their presentation to guide early treatment and intervention. This review briefly discusses the history of troponin testing, before going on to cover clinical uses of the new highly sensitive assays in the early assessment of acute myocardial infection. Common clinical pitfalls with the use of these assays are discussed, as is the use of highly sensitive troponins more widely as prognostic markers. Likely future developments in this area are discussed.

Details

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Cardiac & Cardiovascular Systems

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image